Table 2 Characteristics of the sample (n = 250)
Variable | Categories | Value |
|---|---|---|
Age | Mean= 54 (sd = 13) | |
Gender | Male | 142 (56.8%) |
Living alone | No | 194 (77.6%) |
Employed | Yes | 130 (52.0%) |
Education | until age 11/12 years | 33 (13.2%) |
until age 12/13–14/15 years | 118 (47.2%) | |
until age 15/16–18/19 years | 26 (10.4%) | |
advanced (college) | 73 (29.2%) | |
Nationality | Swiss | 209 (83.6%) |
Immunosuppression | Cyclosporine & mycophenolate mofetil | 71 (28.4%) |
Cyclosporine | 38 (15.2%) | |
Cyclosporine & azathioprine | 37 (14.8%) | |
Azathioprine & prednisone | 18 (7.2%) | |
Azathioprine & tacrolimus | 14 (5.6%) | |
Other combinations | 72 (28.8%) | |
Monitored immunosuppressives | Mycophenolate mofetil | 103 (41.2%) |
Cyclosporine | 89 (35.6%) | |
Azathioprine/prednisone | 19 (7.6%) | |
Tacrolimus | 37 (14.8%) | |
Sirolimus | 2 (0.8%) | |
Self-reported EM influence on typical adherence | No influence | 188 (76.1%) |
Positive influence | 53 (21.5%) | |
Negative influence | 6 (2.4%) |